Novelix Pharmaceuticals Board Approves Q2 FY27 Unaudited Results

Novelix Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on November 11, 2026, approved the standalone unaudited financial results for the quarter and half-year ended September 30, 2026. The board also approved the opening of a new corporate office in Gachibowli, Hyderabad, effective November 16, 2026, and the maintenance of company accounts at this new location. Additionally, Mr. Venkateshwarlu Pulluru's designation was changed from Whole-time Director to Non-Executive Non-Independent Director, effective November 11, 2026. A limited review report on the financial results was also approved.